Pharma Tech Outlook | Advancing Pharma Technology

Chow Woai Sheng, Vice President of Global Instrument Manufacturing and Singapore General Manager, Agilent Technologies | Pharma Tech Outlook Europe

Pharma Manufacturing

Shaping the Next Chapter of Manufacturing

By Chow Woai Sheng, Vice President of Global Instrument Manufacturing and Singapore General Manager, Agilent Technologies

Pfizer [NYSE:PFE]
Three C's to Enable Continuous Development and Manufacturing for Small Molecule Active Pharmaceutical Ingredient
Nick Thomson, Senior Director, Chemical Research and Development, Pfizer
BeiGene [SHA: 688235]
Challenges to Clinical System in China
Cheryl Chen, Director of Clinical Operations, BeiGene
Sanofi [EPA: SAN]
Chasing the Miracles of Science to Improve People's Lives
Paul Rowe, MD, ATSF, Senior Vice President, Head of Medical, Specialty Care, Immunology, Sanofi
Viatris Inc. [NASDAQ: VTRS]
Real-World Data Discoverability
Kelly H. Zou, Ph.D., PStat®, FASA, Head, Global Medical Analytics and Real World Evidence Clinical Development and Medical Affairs, Viatris Inc.
Lonza [SWX: LONN]
Potential of Cell and Gene Therapy
Alexis Bossie, Head of Media R&D, Lonza
Agios Pharmaceuticals [NASDAQ: AGIO]
An Era of Digital Initiatives in Medical Affairs
Eva Gallagher, Vice President, Head of Global Medical Affairs, Agios Pharmaceuticals
Mallinckrodt Pharmaceuticals [NYSE: MNK]
Quality Assurance Transformations and Innovations in Pharma Tech
Tony Johnson, Senior Director, Global Clinical Quality Assurance, Mallinckrodt Pharmaceuticals
Novartis [SWX: NOVN]
Measurement of a Compliance Programme
Rauno Hoffmann, Global Head of Corporate Compliance Management System
Novo Nordisk [CPH: NOVO-B]
Strengthening Patient Centricity in Drug Development: The New Evolution in Pharma
Liselotte Hyveled, Board member
Sanofi CHC [EPA: SAN]
A Holistic Approach to Integrated Marketing and Responsible Leadership
Cynthia Lopez, Global Marketing Excellence Director, Sanofi CHC

Pharma Consulting

Alexander Bernikov, Medical Director, Clinical Development (Uro)-Oncology, Jiangsu Hengrui Pharmaceuticals | Pharma Tech Outlook Europe

Leveraging AI/ML to Transform Pharmaceutical Industry

Alexander Bernikov, Medical Director, Clinical Development (Uro)-Oncology, Jiangsu Hengrui Pharmaceuticals

Erik Lemay, Global Head of External Manufacturing, Servier | Pharma Tech Outlook Europe

Overcoming The Medical Industry's Supply Chain Challenges

Erik Lemay, Global Head of External Manufacturing, Servier

Stewart Campbell, VP & General Manager, West Pharmaceutical Services, Inc. And Li Chen, VP & General Manager,West Pharmaceutical Services, Inc. | Pharma Tech Outlook Europe

How can Manufacturing Companies Keep Pace with the Shifting Trends of Oncology Drug Development

Stewart Campbell, VP & General Manager, West Pharmaceutical Services, Inc.

Pharma Marketing

Robert Zanon, General Manager, Quality at Probiotec | Pharma Tech Outlook Europe

Significance of GMPs in Pharmaceutical Manufacturing

Robert Zanon, General Manager, Quality at Probiotec

Inguna Adoviča, Head of Clinical Research Quality Division, & Vadims Ķīsis, Head of Medicine and Clinical Research Department, JSC Olainfarm | Pharma Tech Outlook Europe

Risk-Based Approach in Vendor Assessment for Clinical Trials (CT) Services

Inguna Adoviča, Head of Clinical Research Quality Division, & Vadims Ķīsis, Head of Medicine and Clinical Research Department, JSC Olainfarm

Line Bentsen Zacho, Marketing Director, Orifarm | Pharma Tech Outlook Europe

From Pharmaceutical Parallel Importer to Building Brands

Line Bentsen Zacho, Marketing Director, Orifarm

Drug Discovery and Development

Ines Silva, Regulatory Strategy Director, ICON Strategic Solutions | Pharma Tech Outlook Europe

Regulatory Strategy, The Maestro

Ines SilvaRegulatory Strategy DirectorICON Strategic Solutions

Rafal Lunio, Director of Research & Development; Qualified Person (QP), Polfa Tarchomin S.A | Pharma Tech Outlook Europe

Early R&D Decisions Shaping Generic Drug Regulatory Success

Rafal LunioDirector of Research & Development; Qualified Person (QP)Polfa Tarchomin S.A

James Streeter, Global VP Life Sciences Strategy, Oracle Health Sciences | Pharma Tech Outlook Europe

Can Expanding Data Sources in Pharma lead to Faster Drug Development?

James Streeter, Global VP Life Sciences Strategy, Oracle Health Sciences

CRO

Leyla Hannbeck, Chief Pharmacist and Director of Pharmacy, National Pharmacy Association | Pharma Tech Outlook Europe

Electronic Prescription Service (EPS) and Controlled Drug (CD) Prescribing

Leyla Hannbeck, Chief Pharmacist and Director of Pharmacy, National Pharmacy Association

Karolina Komposh, Labelling & Artwork, Croma-Pharma | Pharma Tech Outlook Europe

The European Medical Devices Regulation in the Scope of Labelling and Artwork

Karolina Komposh, Labelling & Artwork, Croma-Pharma

James Anderson, Director, Information Services - Business Relationship Management, Astellas Americas | Pharma Tech Outlook Europe

Effective use of Data and IT Management

James Anderson, Director, Information Services - Business Relationship Management, Astellas Americas

BioTech Startup

Janis Naeve, Partner, Cota Capital | Pharma Tech Outlook Europe

Driving Healthcare Transformation through Innovative Investment Approaches

Janis Naeve, Partner, Cota Capital

In The News

Technological Advancements Revolutionizing Pharma Industry

Enhancing Patient Care through Effective Medical Staff Training

A New Way of Looking At Patient Safety And Quality Improvement

Utilizing Care Management to Reduce Length Of Stay And Improve Patient Outcomes